Service
Our Discovery Services are delivered via OXGENE, a WuXi Advanced Therapies Company in the UK which was acquired in 2021. These services are designed to help pioneering companies accelerate the discovery, and development of innovative cell and gene therapies. Since their acquisition, all of OXGENE’s services and technologies have been seamlessly integrated with WuXi Advanced Therapies’ proven GMP manufacturing and testing platforms to further accelerate timelines.
Meet with our Discovery Services team
Expert-led customized engagement and off-the-shelf tools and technologies accelerate the design and development of advanced therapies.
OXGENE’s SnapFast™ plasmids are versatile and efficient. These modular plasmids are designed to work like ‘molecular building blocks’, using a catalogue of well characterized DNA elements that can be easily and reliably inserted into specific locations within the plasmid to generate large numbers of custom constructs across a range of expression platforms.
You can purchase off-the-shelf (OTS) plasmids or work with our team to develop custom plasmids.
OXGENE’s SnapFast™ plasmids are versatile and efficient. These modular plasmids are designed to work like ‘molecular building blocks’, using a catalogue of well characterized DNA elements that can be easily and reliably inserted into specific locations within the plasmid to generate large numbers of custom constructs across a range of expression platforms.
You can purchase off-the-shelf (OTS) plasmids or work with our team to develop custom plasmids.
Learn MoreThe team at OXGENE will work with you to facilitate early-stage screening and optimization of production systems and help you identify the best elements for process development and manufacturing scale-up.
We offer a comprehensive range of technologies and platforms, from transient transfection to cutting-edge solutions, such as TESSA® and XOFLX™, tailored to meet your specific needs.
Our capabilities extend to analytical methodologies for the titration and quality control of viral vectors.
Learn MoreOur team will work with you to engineer and design a custom cell line to meet the needs of your project, or we can provide our XOFLX™ stable cell lines for lentivirus vector manufacture (packaging and producer cell lines.)
OXGENE experts have experience using a variety of cell types as starting materials, including adherent or suspension cell lines, and primary cells. Our plasmid engineering team will provide expertise and guidance on construct design as required.
Both viral and non-viral approaches are available.
Learn More
